Sterile compounding is an essential component of pharmacy practice for pharmacists and pharmacy technicians and efforts to identify and reduce potential adverse events during the preparation of sterile products is imperative to providing safe, optimal patient care.
Pharmacy technicians are instrumental to the sterile compounding process. In addition to preparing compounded sterile preparations, pharmacy technicians seeking career advancement have also been known to lead efforts for ensuring compliance with regulatory standards, train students and other technicians, optimize workflow, perform environmental and product testing, implement, and maintain sterile compounding technology, and prevent medication errors in the compounding process. Advancing sterile compounding expertise and sharing accountability for job responsibilities is key, as it makes crucial positions more rewarding, and extends everyone's ability to accomplish more for patient safety.
Join the interdisciplinary faculty in this CE program and investigate the essential role that both pharmacists and technicians play when working together in advancing safety in the sterile compounding environments.
The intended audience includes: Pharmacists and Pharmacy Technicians involved in Sterile Compounding, administrators with oversight of Pharmacy Practice, Medication Safety Officers, Quality Improvement and Risk Management professionals, Pharmacy Faculty and Students. Upon completion of this activity, participants will be able to:
- Describe the most common error types associated with the preparation of compounded sterile preparations in the pharmacy.
- Identify key safety practices for the reduction of risk during sterile compounding.
- Describe the leadership role pharmacy technicians can play in ensuring medication safety and regulatory compliance for sterile compounding.
Rita K. Jew, PharmD, MBA, BCPPS, FASHP, President, ISMP
Angelic Henson-Ervin, CPhT, Sterile Compounding Quality Improvement Specialist- Compliance
Department of Pharmaceutical Services, UCSF Medical Center, Assistant Clinical Instructor WOS, UCSF School of Pharmacy
Release Date: May 25, 2022
Expiration Date: May 25, 2024
Pharmacists and Pharmacy Technicians
This CE activity is jointly provided by ProCE, LLC and the Institute for Safe Medication Practices (ISMP). ProCE is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 0221-9999-22-194-H05-P/T has been assigned to this knowledge-based home-study CE activity. This activity is approved for 1.0 contact hour (0.1 CEU) in states that recognize ACPE providers. This CE activity is provided at no cost to participants. Statements of completion will be issued online at www.ProCE.com upon completion of the evaluation and post-test with a score of 70% or higher. Proof of completion will be posted in NABP CPE Monitor profiles. No partial credit will be given.
ProCE, LLC requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to ProCE policy. ProCE is committed to providing its learners with high-quality CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company. Angelic Henson-Ervin, CPhT, does not have any relevant commercial and/or financial relationships to disclose. Rita K. Jew, PharmD, MBA, BCPPS, FASHP, has served as a consultant/advisor/speaker for Omnicell, Bainbridge Health and TB Alliance and has stock or options in pharmaceutical companies. Conflicts identified were resolved with a peer review process.
This CE activity is supported by an educational grant from Baxter.
The material presented in this CE activity does not reflect the views of ProCE, LLC or the commercial sponsor. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.